Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
TG Therapeutics Inc (NASDAQ: TGTX) closed the day trading at $35.4 down -1.64% from the previous closing price of $35.99. In other words, the price has decreased by -$1.64 from its previous closing price. On the day, 1.53 million shares were traded. TGTX stock price reached its highest trading level at $36.9099 during the session, while it also had its lowest trading level at $35.1.
Ratios:
For a better understanding of TGTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.04 and its Current Ratio is at 4.02. In the meantime, Its Debt-to-Equity ratio is 1.07 whereas as Long-Term Debt/Eq ratio is at 1.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on October 29, 2024, initiated with a Buy rating and assigned the stock a target price of $50.
On August 02, 2023, Goldman Upgraded its rating to Neutral which previously was Sell and also lowered its target price recommendation from $16 to $12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 13 ’25 when Echelard Yann sold 10,000 shares for $36.94 per share. The transaction valued at 369,400 led to the insider holds 228,816 shares of the business.
Echelard Yann bought 10,000 shares of TGTX for $369,348 on Jun 13 ’25. On Jan 03 ’25, another insider, Power Sean A, who serves as the CFO of the company, sold 11,337 shares for $30.29 each. As a result, the insider received 343,443 and left with 670,632 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TGTX now has a Market Capitalization of 5710409728 and an Enterprise Value of 5226260480. As of this moment, TG’s Price-to-Earnings (P/E) ratio for their current fiscal year is 145.08, and their Forward P/E ratio for the next fiscal year is 20.21. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.95. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.54 while its Price-to-Book (P/B) ratio in mrq is 23.60. Its current Enterprise Value per Revenue stands at 13.526 whereas that against EBITDA is 87.296.
Stock Price History:
The Beta on a monthly basis for TGTX is 1.91, which has changed by 0.8839809 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, TGTX has reached a high of $46.48, while it has fallen to a 52-week low of $16.65. The 50-Day Moving Average of the stock is -4.53%, while the 200-Day Moving Average is calculated to be 8.73%.
Shares Statistics:
Over the past 3-months, TGTX traded about 2.50M shares per day on average, while over the past 10 days, TGTX traded about 1696440 shares per day. A total of 158.17M shares are outstanding, with a floating share count of 142.87M. Insiders hold about 10.00% of the company’s shares, while institutions hold 62.51% stake in the company. Shares short for TGTX as of 1749772800 were 23697171 with a Short Ratio of 9.46, compared to 1747267200 on 22571826. Therefore, it implies a Short% of Shares Outstanding of 23697171 and a Short% of Float of 19.520001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
